Avanir Receives Approval Letter
Avanir Pharmaceuticals (AVNR) received an approvable letter from the Food and Drug Administration rather than an outright approval for its emotional expression disorder treatment. The stock price plummeted $3.42 to close at $3.98.
0 Comments:
Post a Comment
<< Home